No Data
Exact Sciences Initiated at Sector Outperform at Scotiabank on Advanced Diagnostics
Exact Sciences Initiated at Sector Outperform by Scotiabank
Jefferies Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $75
Scotiabank Initiates Exact Sciences at Sector Outperform With $70 Price Target
Express News | Exact Sciences Corp : Btig Cuts Target Price to $70 From $80
Express News | Exact Sciences Corp : Scotiabank Initiates Coverage With Sector Outperform Rating; Target Price $70